Header cover image

Investing Ideas
/
Swiss Pharmaceuticals & Biotech Top Stock Picks from Analysts

Swiss Pharmaceuticals & Biotech Top Stock Picks from Analysts

Results

7

1 new

Companies which are more than 50% undervalued based on analyst price target.

7 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	COPN New Cosmo Pharmaceuticals	CHF 64.00	-1.8%	69.3%	CHF 1.0b	CHF 97.30	PE15.8x	E18.4%	2.9%
	BSLN Basilea Pharmaceutica	CHF 41.20	-4.4%	15.2%	CHF 499.4m	CHF 77.25	PS3.4x	E26.9%	0%
	MOLN Molecular Partners	CHF 5.10	6.4%	27.5%	CHF 188.0m	CHF 9.75	PS31.3x	E-1.2%	n/a
	IDIA Idorsia	CHF 0.95	3.1%	-55.4%	CHF 179.2m	CHF 1.60	PS2.4x	E15.1%	n/a
	NWRN Newron Pharmaceuticals	CHF 7.38	-7.2%	50.6%	CHF 143.6m	CHF 14.42	PS22x	E56.5%	n/a
	SANN Santhera Pharmaceuticals Holding	CHF 8.45	-4.4%	-15.7%	CHF 102.3m	CHF 32.00	PE1.6x	E35.4%	n/a
	ADXN Addex Therapeutics	CHF 0.064	-20.0%	39.1%	CHF 6.3m	CHF 0.16	PS7.3x	E33.3%	n/a

Page 1 of 1